This project presents a pipeline for identifying key protein biomarkers from high-dimensional tumor proteomics data using robust preprocessing, dimensionality reduction, and clustering techniques.

ğŸ“ Dataset
Samples: 42 tumor patients

Features: 8,071 protein expression levels

Missing Data: ~40% of the dataset

ğŸ§¹ Data Preprocessing
Applied variance-normalized KNN (var-norm KNN) to impute missing values.

The method considers the variance of each feature during KNN-based restoration, improving imputation quality and downstream analysis reliability.

ğŸ“‰ Dimensionality Reduction
Used Sparse Principal Component Analysis (Sparse PCA) to reduce dimensionality while preserving interpretability.

Identified 50 key features (biomarkers) that captured 97% of the total variance in the dataset.

ğŸ” Clustering & Feature Selection
Implemented Robust Sparse K-means Clustering (RSKC) to perform simultaneous clustering and feature selection.

Isolated 24 discriminative proteins that contributed most to sample separation.

Achieved a 63% classification accuracy, indicating meaningful biological subgroup differentiation.

ğŸ’¡ Objective
To enable exploratory biomarker discovery in small-sample, high-dimensional omics data by integrating robust imputation, interpretable feature reduction, and sparse clustering.

